Background/Aims: Hepatocellular carcinoma (HCC) is the most prevalent subtype of primary liver tumor worldwide. Growing evidence has led to a consensus that long non-coding RNAs (lncRNAs) have considerable influence on tumorigenesis and tumor progression of HCC via the mechanism of competing endogenous RNAs (ceRNAs). Methods: Here, we systematically investigated the expression landscape and clinical prognostic value of lncRNAs, micorRNAs (miRNAs), and mRNAs from The Cancer Genome Atlas. Differentially expressed RNAs were submitted to Cox regression analysis and the construction of prognostic indexes. A lncRNAmiRNA-mRNA regulatory network was then constructed based on interaction information derived from miRcode, TargetScan, miRTarBase, and miRDB. Gene Ontology and Kyoto Encyclopedia of Genes and Genomes analyses were performed to reveal and determine the functional roles of the ceRNA network in the prognosis of HCC. Results: We detected 77 differentially expressed lncRNAs, 29 differentially expressed miRNAs, and 1014 differentially expressed mRNAs in HCC, which were significantly associated with the overall survival of patients with HCC. We developed three prognostic prediction models that showed moderate predicting prognosis performance and were highly correlated with tumor burden, histological grade and pathological stage. Additionally, 10 survival-related lncRNAs, 6 survival-related miRNAs, and 31 survival-related mRNAs were included to develop a ceRNA network. Further functional enrichment analysis suggested that the ceRNA network was associated with a dismal prognosis for patients with HCC by disturbing the homeostasis of the cell cycle.
Genome

Introduction
Hepatocellular carcinoma (HCC), the most prevalent subtype of primary liver tumor, is a fearsome disease, and its mortality rate, which has been increasing in the United States, has risen by approximately 3% per year in the past few years [1] . Worldwide, HCC risk factors mainly include hepatitis B or C virus infection, aflatoxin B1, alcohol, cirrhosis, and metabolic disorders [2] [3] [4] . The process underlying the onset and progression of HCC is complex and involves many factors, but the precise molecular events that underlie the poor prognosis of HCC remain obscure. To date, the continuous advancement in medical technology, including liver transplantation, surgical resection, and radiofrequency ablation, is still unable to elevate the dismal 5-year survival rate of patients with HCC, which is lower than 20% [5, 6] . The undesirable prognosis of HCC is largely due to limited knowledge of the molecular factors involved in HCC, which leads to the lack of effective interventions [7, 8] . Thus, further characterization of the genetic mechanism and identification of reliable biomarkers to predict HCC prognosis are important steps toward developing more rational, specific, and effective treatments.
Long non-coding RNAs (lncRNAs) are a class of noncoding functional RNAs that have recently attracted increasing research attention [9] . Initially, lncRNAs were regarded as "dark matter" in the genome. The advancement of high-throughput RNA-sequencing (RNA-seq) led to the discovery of thousands of lncRNAs. Indeed, lncRNAs exert significant regulatory roles in diverse cellular processes, especially in various types of tumor [10] [11] [12] . Recently, the mechanism of competing endogenous RNAs (ceRNAs) was proposed as a specific regulatory pathway of lncRNAs to explain how they exert their influence on protein levels [13, 14] . The central concept is that ceRNAs control the large-scale transcriptome by interacting with microRNA (miRNA) response elements (MREs). In recent years, several studies reported that perturbations of lncRNAs could have consequences for the biological process of HCC through the mechanism of ceRNAs, thus affecting the prognosis of HCC [15, 16] . Well-described examples of functionally important lncRNAs, such as the highly up-regulated NEAT1, HULC, all could function by various ceRNA mechanisms to exert indispensable roles in the initiation and progression of HCC [17, 18] . However, most of these studies focused only on the mechanism of a certain lncRNA-miRNA-mRNA axis. Although Zhang et al [19] . constructed a ceRNA network in HCC, they did not proceed from the perspective of prognosis. Therefore, it is important to study comprehensively the effect of a ceRNA network in the context of the poor prognosis of HCC. Through a better understanding of how lncRNAs exert their functions in hepatocarcinogenesis, we might find solutions for the most urgent challenges faced in the management of liver cancer.
To address these challenges, in this study, we comprehensively analyzed and provided an overview of the prognostic roles of different types of RNA (lncRNAs, miRNAs and mRNAs) in HCC. By integrating lncRNAs, miRNAs and mRNAs, we developed a multi-RNA-based individualized prognostic index (PI) to stratify HCC patients effectively into two groups with a significant difference in overall survival (OS). Furthermore, we constructed a prognosticrelated ceRNA network in HCC and concluded with functional enrichment analyses to reveal the underlying mechanism. Via these efforts, we aimed to lay a foundation for the regulatory mechanism of lncRNAs in the prognosis of HCC to identify novel biomarkers that can be used to predict clinical outcome effectively.
Differential analysis
Differentially expressed lncRNAs and mRNAs between HCC and adjacent normal liver tissues were screened by using the edgeR package of R software. |Fold change| > 2 and P-value < 0.05 were set as the thresholds. After normalization by edgeR, the expression profiles of lncRNAs and mRNAs were further converted to log2 (normalized value +1) transformation to be used for the next operation. Similarly, differentially expressed miRNAs were selected by the limma package of R software according to the following criteria: |Fold change| > 2 and P-value < 0.05.
Survival analysis and gene network construction
The clinical parameters of the liver hepatocellular carcinoma cohort were downloaded and extracted from TCGA. Only patients with at least 90 days of OS were included in the survival study. The associations of lncRNAs, miRNAs, and mRNAs with OS were assessed by univariate Cox regression. Only those genes with a P-value < 0.001 were identified as candidate prognosis related biomarkers. Then, those candidate genes were applied by multivariate COX regression to remove any genes that might not be independent factors in prognosis prediction. Finally, lncRNA, miRNA and mRNA signature scores were constructed, respectively, by multiplying the expression levels of independent biomarkers (P-value < 0.01) by the coefficient of multivariate Cox regression. The "SurvivalROC" package in R, which allows for time-dependent receiveroperator characteristic (ROC) curve estimation, was performed to obtain the area under the curve (AUC) of the ROC curve for each model.
CeRNA network construction
The identified prognosis-related lncRNAs, miRNAs and mRNAs were selected to develop the ceRNA network. The miRcode (http://www.mircode.org/) database was used to predict lncRNA-miRNA interactions. miRNA-mRNA interactions were predicted using TargetScan (http://www.targetscan.org/), miRTarBase (http://mirtarbase.mbc.nctu.edu.tw/php/index.php), and miRDB (http://www.mirdb.org/). MiRNA-mRNA interactions that were predicted by the three databases simultaneously were used to construct the ceRNA network. Combining lncRNA-miRNA interactions with miRNA-target gene interactions, a ceRNA regulatory network based on lncRNA-miRNA-mRNA axes was established. Cytoscape software [20] was utilized to draw this network.
Functional analysis
We also performed Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses to reveal and determine the functional roles of the ceRNA network in the prognosis of HCC. These gene functional enrichment analyses were conducted by using the clusterProfiler package of R software. GO terms or KEGG pathways were identified as significantly enriched by these genes when P-value < 0.05. The GOplot package of R software was utilized to display the results of the GO and KEGG analyses. 
Statistical processing
All statistical analyses were conducted using SPSS 24.0 (SPSS, Inc., Chicago, IL, USA). R software (3.3.3 version) and GraphPad Prism 5 were used to plot the figures. The relationships between the gene expression profiles and clinical or demographic characteristics of patients with HCC were calculated using independent sample t-tests. Survival curves were plotted by Kaplan-Meier (K-M) analysis, and differences in survival rates were assessed using a log-rank test.
Results
Differentially expressed lncRNAs, miRNAs, and mRNAs in HCC
We detected differentially expressed genes in 374 HCC tissues and 50 adjacent normal liver tissues. In total, 244 lncRNAs (Fig. 1A) , 106 miRNAs (Fig. 1B) and 2389 mRNAs (Fig.  1C) showed different expression profiles between HCC and non-tumor tissues. Among them, 178 up-regulated lncRNAs and 66 down-regulated lncRNAs were obtained; 1598 mRNAs were up-regulated, and 791 were down-regulated. For the miRNA microarray assay, 106 miRNAs met the selection criteria between the HCC and non-tumor tissues, including 25 up-regulated and 81 down-regulated miRNAs (Fig. 1C) . For the heatmap shown in Fig. 2 , the numerical data represent the expression profiles of differentially expressed lncRNAs ( 
Survival associated lncRNAs, miRNAs, and mRNAs in HCC
The associations between the differentially expressed lncRNAs, miRNAs, and mRNAs with OS were studied in detail in 329 patients with HCC with at least 90 days of OS. We conducted univariate survival analysis to select OSrelated RNAs. As a result, we detected a total of 77 survival associated lncRNAs, 29 survival associated miRNAs, and 1014 survival associated mRNAs in HCC (P-value < 0.05). The top 20 most significant survival associated genes are presented in Fig. 3 . The most significant survival associated mRNAs in HCC (P-value < 0.001) were piped to STRING to generate gene interaction networks, and Cytoscape analysis of the gene networks revealed the important cancer pathways, including hub genes, such as CDK1, CCNB1, and PLK1 (Fig. 4) .
Derivation of prognostic signatures for HCC patients
These most significant survival associated lncRNAs, miRNAs and mRNAs were further submitted to multivariate COX regression analysis to identify the independent prognostic predictors for HCC. Next, the PIs for predicting survival were constructed based on 3 lncRNAs, 3 miRNAs, and 3 mRNAs. The formulae for the three prognostic signatures were and ranked them according to increased risk score. HCC patients were separated into lowor high-risk groups according to the median risk score. K-M analysis showed a significant difference in OS between the two groups with all three models (Fig. 5) . ROC curves were also applied to compare the efficiency of these prognostic models. The three proposed PIs all showed moderate prognostic assessment ability with time-dependent AUC values of 0.728, 0.719, and 0.724, respectively (Fig. 6 ). As shown in Fig. 7 , the scores assigned to each patient provide a good assessment of prognosis. The expression pattern of these RNAs in the highand low-risk groups are also displayed ( Fig. 7G-I) .
Building a prognostic predictor that includes different types of RNA could reveal the potential molecular mechanism of HCC and increase prediction accuracy. Finally, the multiple types of RNA-based PI for HCC OS were selected, including the above nine RNAs. To determine the value of the PI in predicting HCC prognosis, we performed K-M analysis, which revealed that patients in the high-risk group had a shorter OS (hazard ratio [HR] = 4.030, 95% confidence interval [CI]: 2.753-5.898, P-value < 0.001; Fig. 8A ). Furthermore, the AUC of the 
time-dependent ROC curve was 0.776 ( Fig. 8B) . To display the prognostic efficiency of PI more intuitively, we also generated a K-M plot of tumor stage and the corresponding ROC curve. Tumor, node, metastasis (TNM) stage also divided the HCC patients into two groups with a significant difference in prognosis (HR=3.897, 95%CI: 2.399-6.271, P-value < 0.001; Fig. 8C ). The AUC of the ROC curve based on TNM stage was 0.668 (Fig. 8D) 
Clinical significance of prognostic predictors
As prognostic genes involved in the onset and prognosis in HCC, it was most likely that these RNAs could accelerate the development of HCC and be of great significance. Therefore, we analyzed the expression of these genes under various clinical parameters and investigated their associations with clinical progress. We specifically analyzed several major clinical parameters, including age (over or under 60 years), gender (male or female), tumor status (with tumor or tumor free), pathologic stage (Stage III, IV or Stage I, II), T stage (Stage III, IV or Stage I, II), N stage (whether lymphatic metastasis had occurred or not), M stage (whether distant metastasis had occurred or not), and histological grade (III, IV or I, II). The nine genes included in our risk score showed significant correlation with HCC tumor burden, histological grade, and stage (Fig. 9, Tables 2-4 ). These results revealed that these genes can be used for effective risk stratification in HCC. Cellular Physiology and Biochemistry Cellular Physiology and Biochemistry (Fig. 10) . This ceRNA network included some familiar star molecules, such as SNHG3, mir-101-3p and FOXO1. Of course, there are some molecules that are not well understood in HCC. Our ceRNA network provide some novel insights into the diagnosis, surveillance, and prognosis of HCC. Considering the regulatory role of lncRNAs, K-M plots generated by Cutoff Finder [21] were used to show their value in predicting prognosis (Fig. 11) . According to the ceRNA paradigm, lncRNAs compete with protein-coding genes for the pool of shared miRNAs. Thus, we performed a comprehensive integrating analysis to assess whether the mRNAs included in the ceRNA network correlated with the prognosis of HCC patients as a whole. It showed that the overexpression of these mRNAs was significantly associated with poor OS (pooled HR=1.18, 95% CI: 1.08-1.29, P-value < 0.001, random effect; Fig.  12) .
On the basis of enrichment analysis of the network, we found that the genes included in the ceRNA network were highly associated with five KEGG pathways, such as "cell cycle," "P53 signaling pathway," and "microRNAs in cancer" (Fig. 13) .
For the GO functional categories, these genes were mainly involved in several biological processes (BP) that are closely related to the tumor progression. In the cellular component (CC) process, the target genes were significantly clustered into items, including PCG protein complex, chromatin and heterochromatin. Chromatin, transcription factor binding, betacatenin binding, and other vital molecular functions (MF) were significantly related to these genes (P-value < 0.05). The GO enrichment networks of BP, CC and MF for these genes are shown in Fig. 14.
Discussion
It is becoming increasingly clear that many complex diseases, particularly cancers, can rarely be ascribed to one or a few genomic variations alone [22] . Recently, the ceRNA hypothesis has been considered a novel measure of gene regulation at the posttranscriptional level through miRNA competition in HCC [16, 23, 24] . In the present study, to gain insights into the molecular events relevant to HCC prognosis, we took advantage of the molecular resolution provided by TCGA and identified distinct lncRNAs, miRNAs, and mRNAs that together specify biologically relevant HCC prognosis. Particularly, we developed a prognostic ceRNA network according to specific criteria outlined by a large sample of HCC tissues from TCGA, which has provided a deeper understanding of HCC at the integration level, as well as new dimensions to predict the prognosis of individual patients with HCC.
HCC is an overwhelming experience for patients due to its inferior prognosis. Hence, identifying effective prognostic biomarkers and exploring the underlying regulatory network are indispensable steps toward the development of effective therapies and tailored treatment plans. Furthermore, prognostic signatures based on multiple genes have contributed to more accurate predictions of survival compared to single gene analysis. Previous studies mainly focused on one type of RNA. Various prognostic risk models based on lncRNAs [25] , miRNAs [26, 27] and mRNAs [28] have been proposed by different scholars. However, the prognostic value of a PI including different kinds of RNA is still not clear. In the present study, we proposed 3 distinct prognostic signatures based on lncRNAs, miRNAs and mRNAs, respectively, which could successfully predict the survival of patients with HCC. It is worth noting that the genes that were submitted to survival analysis are differentially expressed in HCC; our findings indicated that these genes are expressed during the onset and progression of HCC. Finally, a novel PI that included multiple RNAs was proposed, which was validated as an independent predictor for the OS of patients with HCC. In particular, to obtain more reliable and accurate results, we removed patients with less than 90 days of OS. Additionally, low-abundance genes were also removed when analyzing the relationships between survival and the gene expression profiles. These additional measures provided more accurate results. Furthermore, genes included in our model were closely related with tumor burden, histological grade, and stage. Importantly, these findings provided several clues that the PI may be particularly useful for the assessment of treatment response and recurrence surveillance. Through analysis of survival, we identified several biomarkers with significant clinical significance, some of which have not been reported previously. Three lncRNAs (TMCC1-AS1, LINC01138 and AC009005.1) are rarely reported in HCC. Cui et al [29] . reported that SOCS2 inhibited HCC cell metastasis in vitro and in vivo. Furthermore, it has been reported that HCC patients with low SOCS2 expression have significantly inferior OS [30] . Up-regulated KPNA2 expression has also been identified as a biomarker of poor prognosis in HCC [31, 32] . These reports facilitated the identification of additional biomarkers and improved the accuracy of prognosis prediction.
Several studies have revealed that some dysregulated lncRNAs may act as potential onco-or tumor-suppressor RNAs in numerous cancer types, including gastric cancer [33] , pancreatic cancer [34] and HCC [35] . The ceRNA hypothesis provides a new framework to understand complicated RNA regulatory relationships. Cross-talk is thought to occur between lncRNAs, miRNAs, and mRNAs during all aspects of the HCC process, including metastasis [36] , proliferation and invasion [37, 38] . We proposed a prognostic-related ceRNA network in HCC, aimed to explore the underlying mechanism of the disturbed ceRNA axis, and identified effective prognostic indicators from a comprehensive perspective. In this novel ceRNA network, several oncogenes and tumor suppressors were identified that participate in the development of HCC. The identified lncRNAs showed moderate prognostic value; among them were the lncRNAs SNHG1 [39, 40] , SNHG3 [41] , SNHG6 [42] , SNHG12 
